| 1 | Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Silverberg MS · 2005 · Can J Gastroenterol | | 2,695 |
| 2 | ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. Levine A · 2014 · J Pediatr Gastroenterol Nutr | | 1,097 |
| 3 | Ileal pouch-anal anastomoses complications and function in 1005 patients. Fazio VW · 1995 · Ann Surg | | 958 |
| 4 | Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Beaugerie L · 2009 · Lancet | | 894 |
| 5 | Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Van Limbergen J · 2008 · Gastroenterology | | 743 |
| 6 | Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition · 2005 · J Pediatr Gastroenterol Nutr | | 536 |
| 7 | Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Fazio VW · 2013 · Ann Surg | | 535 |
| 8 | The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Fraser AG · 2002 · Gut | | 507 |
| 9 | The diagnostic approach to monogenic very early onset inflammatory bowel disease. Uhlig HH · 2014 · Gastroenterology | | 502 |
| 10 | Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Strauss J · 2011 · Inflamm Bowel Dis | | 465 |
| 11 | Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Kuenzig ME · 2022 · Gastroenterology | | 462 |
| 12 | Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Solem CA · 2005 · Inflamm Bowel Dis | | 457 |
| 13 | Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. MacDonald TT · 1990 · Clin Exp Immunol | | 441 |
| 14 | Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Vind I · 2006 · Am J Gastroenterol | | 430 |
| 15 | Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Connell WR · 1993 · Gut | | 425 |
| 16 | Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. Heyman MB · 2005 · J Pediatr | | 392 |
| 17 | Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. Turner D · 2018 · J Pediatr Gastroenterol Nutr | | 382 |
| 18 | Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition · 2007 · J Pediatr Gastroenterol Nutr | | 351 |
| 19 | Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. Colman RJ · 2014 · J Crohns Colitis | | 344 |
| 20 | East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Burisch J · 2014 · Gut | | 311 |
| 21 | Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Hahnloser D · 2007 · Br J Surg | | 297 |
| 22 | Current global trends in the incidence of pediatric-onset inflammatory bowel disease. Sýkora J · 2018 · World J Gastroenterol | | 290 |
| 23 | Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Conte MP · 2006 · Gut | | 286 |
| 24 | Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Peeters M · 2001 · Am J Gastroenterol | | 272 |
| 25 | Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Yu YR · 2017 · Semin Pediatr Surg | | 265 |
| 26 | Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Bassi A · 2004 · Gut | | 253 |
| 27 | Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Romberg-Camps MJ · 2009 · Am J Gastroenterol | | 246 |
| 28 | Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Ljung T · 2004 · Gut | | 242 |
| 29 | Primary sclerosing cholangitis: a long-term follow-up study. Aadland E · 1987 · Scand J Gastroenterol | | 241 |
| 30 | Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Bourreille A · 2009 · Endoscopy | | 240 |
| 31 | Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Papadakis KA · 2001 · Am J Gastroenterol | | 228 |
| 32 | Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. Robles AI · 2016 · Gastroenterology | | 222 |
| 33 | The value of serologic markers in indeterminate colitis: a prospective follow-up study. Joossens S · 2002 · Gastroenterology | | 222 |
| 34 | Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016. Ye Y · 2020 · Inflamm Bowel Dis | | 210 |
| 35 | A controlled study of bone mineral density in patients with inflammatory bowel disease. Silvennoinen JA · 1995 · Gut | | 205 |
| 36 | Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Vavricka SR · 2012 · Inflamm Bowel Dis | | 204 |
| 37 | Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific. Ng SC · 2019 · Am J Gastroenterol | | 201 |
| 38 | Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Romberg-Camps MJ · 2010 · Inflamm Bowel Dis | | 194 |
| 39 | Treatment processes for source-separated urine. Maurer M · 2006 · Water Res | | 194 |
| 40 | Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Vavricka SR · 2015 · Inflamm Bowel Dis | | 191 |
| 41 | Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. Bunn SK · 2001 · J Pediatr Gastroenterol Nutr | | 191 |
| 42 | Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Mountifield R · 2009 · Inflamm Bowel Dis | | 189 |
| 43 | Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Molinié F · 2004 · Gut | | 187 |
| 44 | Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden. Everhov ÅH · 2018 · Gastroenterology | | 184 |
| 45 | Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. Kunitake H · 2008 · J Gastrointest Surg | | 184 |
| 46 | Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Castaño-Rodríguez N · 2017 · Gut | | 181 |
| 47 | Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease. Hyams JS · 2017 · Gastroenterology | | 178 |
| 48 | Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Boonstra K · 2012 · Inflamm Bowel Dis | | 175 |
| 49 | Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Long MD · 2011 · Inflamm Bowel Dis | | 173 |
| 50 | High frequency of early colorectal cancer in inflammatory bowel disease. Lutgens MW · 2008 · Gut | | 169 |
| 51 | Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Jose FA · 2009 · Inflamm Bowel Dis | | 167 |
| 52 | Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Pera A · 1987 · Gastroenterology | | 166 |
| 53 | IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology. Jones GR · 2019 · Gut | | 165 |
| 54 | Rising incidence of inflammatory bowel disease among children: a 12-year study. Malaty HM · 2010 · J Pediatr Gastroenterol Nutr | | 164 |
| 55 | Rising incidence of pediatric inflammatory bowel disease in Scotland. Henderson P · 2012 · Inflamm Bowel Dis | | 162 |
| 56 | Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Kappelman MD · 2014 · Clin Gastroenterol Hepatol | | 161 |
| 57 | Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG). Jakobsson GL · 2017 · Scand J Gastroenterol | | 161 |
| 58 | Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases. Tomasello G · 2016 · Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | | 158 |
| 59 | Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Parente F · 2003 · Aliment Pharmacol Ther | | 157 |
| 60 | Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. Billioud V · 2013 · J Crohns Colitis | | 156 |
| 61 | Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Hildebrand H · 2003 · Gut | | 156 |
| 62 | Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Ouahed J · 2020 · Inflamm Bowel Dis | | 155 |
| 63 | Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Gower-Rousseau C · 2013 · Dig Liver Dis | | 155 |
| 64 | Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Moum B · 1996 · Scand J Gastroenterol | | 155 |
| 65 | Serologic markers in inflammatory bowel disease. Bossuyt X · 2006 · Clin Chem | | 154 |
| 66 | Histological evaluation in ulcerative colitis. DeRoche TC · 2014 · Gastroenterol Rep (Oxf) | | 153 |
| 67 | Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). Auvin S · 2005 · J Pediatr Gastroenterol Nutr | | 153 |
| 68 | Serological antibodies in inflammatory bowel disease: a systematic review. Prideaux L · 2012 · Inflamm Bowel Dis | | 152 |
| 69 | Long-term results of ileal pouch-anal anastomosis in patients with Crohn's disease. Sagar PM · 1996 · Dis Colon Rectum | | 151 |
| 70 | Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives. Tontini GE · 2015 · World J Gastroenterol | | 149 |
| 71 | Market share and costs of biologic therapies for inflammatory bowel disease in the USA. Yu H · 2018 · Aliment Pharmacol Ther | | 148 |
| 72 | Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials. Schreiber S · 2019 · Ann Rheum Dis | | 148 |
| 73 | Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort. Shelton E · 2015 · Inflamm Bowel Dis | | 148 |
| 74 | Natural history of pediatric-onset inflammatory bowel disease: a systematic review. Abraham BP · 2012 · J Clin Gastroenterol | | 147 |
| 75 | High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Wilson J · 2010 · Inflamm Bowel Dis | | 146 |
| 76 | Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Ferrante M · 2008 · Inflamm Bowel Dis | | 146 |
| 77 | Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). Fellermann K · 1998 · Am J Gastroenterol | | 145 |
| 78 | Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Lakatos L · 2011 · Inflamm Bowel Dis | | 145 |
| 79 | Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis. Lightner AL · 2017 · Inflamm Bowel Dis | | 145 |
| 80 | Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. Feakins RM · 2013 · J Clin Pathol | | 144 |
| 81 | Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results. Yu CS · 2000 · Dis Colon Rectum | | 143 |
| 82 | High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. Mow WS · 2004 · Clin Gastroenterol Hepatol | | 140 |
| 83 | The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Moskovitz DN · 2004 · Am J Gastroenterol | | 140 |
| 84 | Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Brant SR · 2017 · Gastroenterology | | 138 |
| 85 | Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Vester-Andersen MK · 2014 · Am J Gastroenterol | | 138 |
| 86 | Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Fischer M · 2016 · Inflamm Bowel Dis | | 138 |
| 87 | Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents. Ghione S · 2018 · Am J Gastroenterol | | 138 |
| 88 | Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. Lindberg E · 2000 · J Pediatr Gastroenterol Nutr | | 136 |
| 89 | Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Rahier JF · 2010 · Clin Gastroenterol Hepatol | | 135 |
| 90 | Inflammatory Bowel Disease and Parkinson's Disease: A Nationwide Swedish Cohort Study. Weimers P · 2019 · Inflamm Bowel Dis | | 134 |
| 91 | Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Turunen P · 2006 · Inflamm Bowel Dis | | 134 |
| 92 | Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Pinsk V · 2007 · Am J Gastroenterol | | 131 |
| 93 | Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Reddy D · 2008 · Am J Gastroenterol | | 131 |
| 94 | Immune response to influenza vaccine in children with inflammatory bowel disease. Lu Y · 2009 · Am J Gastroenterol | | 130 |
| 95 | Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. Dotson JL · 2010 · J Pediatr Gastroenterol Nutr | | 130 |
| 96 | Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study. Burisch J · 2020 · Lancet Gastroenterol Hepatol | | 129 |
| 97 | Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme. Razanskaite V · 2017 · J Crohns Colitis | | 128 |
| 98 | Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study. Smits LJ · 2016 · J Crohns Colitis | | 126 |
| 99 | Avoidance of Fiber Is Associated With Greater Risk of Crohn's Disease Flare in a 6-Month Period. Brotherton CS · 2016 · Clin Gastroenterol Hepatol | | 124 |
| 100 | Idiopathic pancreatitis associated with inflammatory bowel disease. Seyrig JA · 1985 · Dig Dis Sci | | 123 |